Cargando…

Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study

BACKGROUND: Recent vasodilating drugs have improved prognosis of Pulmonary arterial hypertension (PAH). Some reports describe the merits of combination therapies for PAH, and this study evaluated the efficacy and safety of phosphodiesterase type 5 inhibitors (PDE5i) combination therapy, using silden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimura, Mai, Tamura, Yuichi, Takei, Makoto, Yamamoto, Tsunehisa, Ono, Tomohiko, Fujita, Jun, Kataoka, Masaharu, Kuwana, Masataka, Satoh, Toru, Fukuda, Keiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436029/ https://www.ncbi.nlm.nih.gov/pubmed/25971443 http://dx.doi.org/10.1186/s12890-015-0037-8

Ejemplares similares

Rapid Initiation of Intravenous Epoprostenol Infusion Is the Favored Option in Patients with Advanced Pulmonary Arterial Hypertension
por: Kimura, Mai, et al.
Publicado: (2015)

Human Pentraxin 3 (PTX3) as a Novel Biomarker for the Diagnosis of Pulmonary Arterial Hypertension
por: Tamura, Yuichi, et al.
Publicado: (2012)

Temperature Variations around Medication Cassette and Carry Bag in Routine Use of Epoprostenol Administration in Healthy Volunteers
por: Tamura, Yuichi, et al.
Publicado: (2012)

Arterial methemoglobin level predicts therapeutic effectiveness of the PDE5 inhibitors in patients with in idiopathic pulmonary arterial hypertension
por: Tamura, Yuichi, et al.
Publicado: (2011)

Safety and Efficacy of Ambrisentan–Phosphodiesterase Type 5 (PDE5) Inhibitor Combination Therapy for Japanese Pulmonary Arterial Hypertension Patients in Real-World Clinical Practice
por: Kataoka, Masaharu, et al.
Publicado: (2019)

Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)
por: Tamura, Yuichi, et al.
Publicado: (2013)

Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
por: Tamura, Yuichi, et al.
Publicado: (2013)

A genome-wide association analysis identifies PDE1A|DNAJC10 locus on chromosome 2 associated with idiopathic pulmonary arterial hypertension in a Japanese population
por: Kimura, Mai, et al.
Publicado: (2017)

Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension
por: Tanaka, Hiroaki, et al.
Publicado: (2017)

Pulmonary Artery Pressure as a Treatment Target to Improve the Prognosis of Idiopathic Pulmonary Arterial Hypertension　― Insight From a Cohort From Two Japanese Pulmonary Hypertension Centers ―
por: Ishiguro, Midori, et al.
Publicado: (2020)

Improvements in French risk stratification score were correlated with reductions in mean pulmonary artery pressure in pulmonary arterial hypertension: a subanalysis of the Japan Pulmonary Hypertension Registry (JAPHR)
por: Tamura, Yuichi, et al.
Publicado: (2021)

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension
por: Furuya, Yoshiaki, et al.
Publicado: (2010)

A New Era of Therapeutic Strategies for Chronic Thromboembolic Pulmonary Hypertension by Two Different Interventional Therapies; Pulmonary Endarterectomy and Percutaneous Transluminal Pulmonary Angioplasty
por: Inami, Takumi, et al.
Publicado: (2014)

Negative legacy of obesity
por: Shirakawa, Kohsuke, et al.
Publicado: (2017)

Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension
por: Tamura, Yuichi, et al.
Publicado: (2022)

Assessment of Physical Activity Using Waist-Worn Accelerometers in Hospitalized Heart Failure Patients and Its Relationship with Kansas City Cardiomyopathy Questionnaire
por: Shiraishi, Yasuyuki, et al.
Publicado: (2021)

Successful depiction of systemic collateral supply to pulmonary artery in CTEPH using time-resolved 4D CT angiography: a case report
por: Tamura, Masashi, et al.
Publicado: (2020)

The pseudo-single-crystal method: a third approach to crystal structure determination
por: Kimura, Tsunehisa, et al.
Publicado: (2009)

“Paradoxical” findings of tumor vascularity and oxygenation in recurrent glioblastomas refractory to bevacizumab
por: Yamamoto, Yohei, et al.
Publicado: (2017)

(Pro)renin receptor accelerates development of sarcopenia via activation of Wnt/YAP signaling axis
por: Yoshida, Naohiro, et al.
Publicado: (2019)

Autoimmune hypophysitis as a cause of adrenocorticotropic hormone deficiency in pulmonary arterial hypertension: a case report
por: Ichihara, Genki, et al.
Publicado: (2021)

Regional Right Ventricular Abnormalities Implicate Distinct Pathophysiological Conditions in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Moriyama, Hidenori, et al.
Publicado: (2020)

Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis
por: Kuwana, Masataka, et al.
Publicado: (2020)

Omega-3 fatty acid epoxides produced by PAF-AH2 in mast cells regulate pulmonary vascular remodeling
por: Moriyama, Hidenori, et al.
Publicado: (2022)

Strategies for regulating tissue fibrosis and their clinical application
por: Kuwana, Masataka
Publicado: (2020)

Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop
por: Masuda, Ayako, et al.
Publicado: (2013)

Cardiomyocyte-Specific Overexpression of HEXIM1 Prevents Right Ventricular Hypertrophy in Hypoxia-Induced Pulmonary Hypertension in Mice
por: Yoshikawa, Noritada, et al.
Publicado: (2012)

Decrease in membrane phospholipids unsaturation correlates with myocardial diastolic dysfunction
por: Yamamoto, Tsunehisa, et al.
Publicado: (2018)

PEDT-03 A clinical trial of dendritic cell-based immunotherapy for refractory brain tumors in children
por: Akasaki, Yasuharu, et al.
Publicado: (2020)

The phosphodiesterase 5 inhibitor tadalafil has renoprotective effects in a rat model of chronic kidney disease
por: Tomita, Natsumi, et al.
Publicado: (2020)

Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension
por: Murata, Mitsushige, et al.
Publicado: (2017)

Exercise prescription using an insertable cardiac monitor in a patient with catecholaminergic polymorphic ventricular tachycardia
por: Momoi, Mizuki, et al.
Publicado: (2021)

Effect of Roflumilast in airways disorders via dual inhibition of phosphodiesterase and Ca(2+)-channel
por: Imam, Faisal, et al.
Publicado: (2020)

Rv2577 of Mycobacterium tuberculosis Is a Virulence Factor With Dual Phosphatase and Phosphodiesterase Functions
por: Forrellad, Marina Andrea, et al.
Publicado: (2020)

Dual Activation of Phosphodiesterase 3 and 4 Regulates Basal Cardiac Pacemaker Function and Beyond
por: Vinogradova, Tatiana M., et al.
Publicado: (2021)

Establishment and Industrialization of a New Treatment Method Using Regenerative Cardiomyocyte Transplantation for Refractory Severe Heart Failure - Secondary Publication
por: Fukuda, Keiichi
Publicado: (2023)

Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis
por: Yamaguchi, Yukie, et al.
Publicado: (2010)

Reflectance spectra analysis for mucous assessment
por: Chiba, Toru, et al.
Publicado: (2021)

Phosphodiesterase-III Inhibitor Prevents Hemorrhagic Transformation Induced by Focal Cerebral Ischemia in Mice Treated with tPA
por: Ishiguro, Mitsunori, et al.
Publicado: (2010)

Updates on genetics in systemic sclerosis
por: Ota, Yuko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fn2ri0pqlh6g69l3jloe1sjfkm